MSD wins FDA approval for cholesterol pill to help plug Keytruda void
MSD (Merck & Co) has won US Food and Drug Administration (FDA) approval for its cholesterol-lowering pill, marking a significant…
All articles by Robert Barrie
Robert Barrie
Robert Barrie is a news and features reporter for Pharmaceutical Technology. He holds a BSc in Neuroscience and his interests include infectious diseases, weight loss therapies, and health politics. Contact Rob
-
-
UK commits to pharma IP protection in Swiss trade deal
The UK government has committed to maintaining its existing intellectual property (IP) framework for pharmaceuticals as part of a new…
-
Novo secures European approval for oral Wegovy to extend lead over Lilly
Novo Nordisk is continuing to maintain its advantage in the obesity pill race after winning European approval for oral Wegovy…
-
Women’s health attracted record equity in 2025 as companies share capital
Women’s health companies secured a record $1.55bn in funding in 2025, hinting that investors' faith is growing in this sector.…
-
AstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug
AstraZeneca has acquired the global rights to Dizal Pharmaceutical’s Zegfrovy (sunvozertinib), marking the drugmaker’s second venture to China in a…
-
Germany approves healthcare costs overhaul despite significant pharma opposition
Lawmakers in Germany have passed a bill that will cut health insurance costs in a shakeup that has generated strong…
-
“Hub-and-spoke” drug manufacturing set to benefit from new FDA rule
The US Food and Drug Administration (FDA) has proposed a new rule that will simplify the registration step for certain…
-
Chinese biotech MindRank secures $52m to advance AI-designed oral GLP-1RA
MindRank has raised $52m to advance its pipeline of candidates discovered and designed by artificial intelligence (AI), including a lead…
-
Moderna secures up to 24 million RSV vaccine dose contract with Europe
Moderna has agreed a contract with the European Commission (EC) that will see tens of millions of respiratory syncytial virus…
-
Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant
Novo Nordisk has taken an interest in a weight-loss implant developed by Californian medtech Vivani Medical, reflecting a broadening of…